Skip to main content
. Author manuscript; available in PMC: 2017 Jul 5.
Published in final edited form as: J Pediatr. 2008 Jun 24;153(5):677–682. doi: 10.1016/j.jpeds.2008.04.065

Table 3.

Plasma levels of peptide YY, TNF-α and IL-1β of cases at visit 1, cases at visit 2 and controls. Cases are Peruvian children ages 12 to 71 months who had diarrhea at visit 1 and were healthy at visit 2. Cases are healthy age-matched children from the same peri-urban community.

Peptide YY (pg/mL) TNF-α (pg/mL) IL-1β (pg/mL)
Cases Visit 1 53.5a (± 30.7) 69.8c (± 43.1) 12.2 (± 13.1)
Cases Visit 2 38.8b (± 14.0) 58.0d (± 54.1) 14.3 (± 11.0)
Controls 33.5 (± 16.4) 46.8 (± 17.5) 15.3 (± 31.0)
1

Visit 2 was 10 days or more after visit 1.

a

Significantly different from mean peptide YY of controls (p=.0005)

b

Difference from mean peptide YY of cases at visit 1 of borderline significance (p=.06)

c

Significantly different from mean TNF-α of controls (p=.0008)

d

Significantly different from mean TNF-α of cases at visit 1 (p=.0026)